The objective of this study is to determine whether high dose Coenzyme Q10 slows the course of ALS. This is a randomized, placebo-controlled, double-blind, multi-center trial in which neither participants nor researchers know who is taking which substance.
Read more...
| Reasons used |
# of patients
Efficacy
|
Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| General health | 1 | 0 | |||||
| Progressive Supranuclear Palsy PSP | 1 | 0 | |||||
| High blood pressure (Hypertension) | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Expense
|
1 | 100% |
|
Stopped Using CoQ10 Study
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on March 19, 2010.